Notably, pharmacological inhibition of CD40 using TRAF-STOP not only effectively suppressed Fn-induced NF-κB activation and ameliorated colitis severity, but also restored immune balance by reducing Th17 cells and increasing Treg cells. Here, NFKB1 is linked to colitis.